Concepedia

Russell Karp

RK

16

Publications

1.8K

Citations

13

H-Index

1976

Active since

Affiliations

Clovis Oncology (United States)(Current)

Case Western Reserve University

Tris Pharma (United States)

United States Military Academy

University Hospitals of Cleveland

Russell Karp is an author at Clovis Oncology (United States) specializing in medicine, pharmacology, and immunology.

ORCID

Top concepts

Publications per year

1976–2020

16

Publications

16

Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC

Annette O. Walter, Robert Tjin Tham Sjin, Henry J. Haringsma et al. · Cancer Discovery · 2013 · 622 citations · Full text

Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs

Susannah L. Hewitt, Ailin Bai, D. R. Shackleton Bailey et al. · Science Translational Medicine · 2019 · 286 citations

Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans

Erica N Evans, Richland Tester, Sharon Aslanian et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 219 citations

Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment

Susannah L. Hewitt, D. R. Shackleton Bailey, John Zielinski et al. · Clinical Cancer Research · 2020 · 206 citations · Full text

Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine

Margit Hagel, Deqiang Niu, Thia St Martin et al. · Nature Chemical Biology · 2010 · 92 citations

, , +8

Rows per page

1–5 of 16